Women who rely on Essure for birth control claim that the device has caused severe side effects and other problems. Some of these side effects include cramping, persistent pain in the pelvic cavity, nausea and vomiting, dizziness, irregular periods and bleeding, bloating, constant feelings of discomfort, itchy skin, and more.

Essure has also been associated with more severe side effects, including device migration, perforation of the uterus and fallopian tubes by the device, severe allergic reactions, unplanned pregnancies, dangerous ectopic pregnancies, and even death.

Patients who have suffered injuries from an Essure birth control device will be actively looking for a product liability law firm for legal representation. Broughton Partners connects personal injury law firms with Essure lawsuit leads and other defective medical device leads. The Essure leads your law firm receives are qualified retainers who have been fully reviewed for lawsuit eligibility. Your law firm can get Essure lawsuit leads delivered with relevant case documents by contacting our team at (912)-304-4444 or fill out a quick online form for a free consultation.

JUMP TO

What is Essure?

Essure is a permanent birth control device designed to prevent pregnancy without the need for surgery. Essure is the only type of birth control device on the market designed to permanently prevent pregnancy without surgery. This makes it an attractive option for many women because they can get back to their normal daily activities almost immediately. Essure is made of two small coils that are placed into the fallopian tubes and is intended to cause inflammation and scar tissue that forms and blocks the tubes, preventing pregnancy.

The maker of the Essure device claims it is effective and safe with an easy insertion procedure
Essure is a permanent, non-surgical birth control device designed to prevent pregnancy in women. It is the only one of its kind on the market intended to avoid pregnancy without a surgical procedure permanently. For this reason, Essure is an attractive option for many women, as they can return to their regular activities almost immediately after insertion.

Essure Linked to Complications

Women who want to prevent pregnancy permanently and had the Essure device implanted are coming forward to report complications.

Risks of Essure

Chronic pelvic pain
Heavy bleeding in between periods
Bowel Problems
Perforation of the uterus or fallopian tubes
Unintended pregnancy
Unexpected movement of the device

Claims Against Essure

Essure has forced a patient to undergo additional and/or revision surgery beyond the implantation
Essure was improperly placed during the procedure
Essure caused tearing or perforation of the fallopian tubes or nearby organs
Essure has moved or migrated after implant surgery
Bayer did not give adequate warnings to patients and doctors about the dangerous Essure side-effects
Essure was defectively designed and led to severe complications
Essure has caused allergic and immune reactions and recurring pain

Essure Lawsuit

Thousands of complaints have been reported to the U.S. Food and Drug Administration by women who rely on Essure for birth control and have suffered from pain and other side effects. Some of these side effects include cramping, bloating, nausea and vomiting, persistent pain in the pelvic cavity, dizziness, bleeding and irregular periods, constant discomfort, skin itching, and much more.

The device has even more severe side effects, including migration of the device, perforation of the uterus and/or fallopian tubes by the device, device breakage, severe allergic reactions, unintended pregnancies, ectopic pregnancies, and even death.

The FDA has received tens of thousands of adverse event reports documenting these side effects. Since Essure is a permanent birth control device, many women who suffer from side effects choose to have hysterectomies to remove the device.

Injured women continue to file Essure lawsuits in state courts all over the country. There have been a few setbacks but courts have made progress and qualified retainers are being filed in a consolidated docket in the Superior Court for the State of California in Alameda County. California, Illinois, and Pennsylvania courts are in the process of selecting bellwether trial qualified retainers and setting trial dates for 2019 and 2020. Both parties are exchanging general discovery and the plaintiffs have taken several depositions of employees from Bayer. Specific plaintiff claims are not expected to begin until early 2020.

November 2002

The FDA approves Essure as a Class III medical device and markets the device as a promising and safe option for female birth control.

2011

Angie Firmalino, now an advocate for women’s health, has her Essure implant removed after it caused severe injuries and constant bleeding. Firmalino began an “Essure Problems” Facebook group and has been featured in the Netflix documentary, The Bleeding Edge, which showqualified retainers the fight against Essure.

2014

The FDA orders Essure manufacturer, Bayer, to conduct a new clinical trial based on adverse event reports filed.

2015

Women who were harmed by the device first began filing lawsuits in late 2015

September 2015

The FDA advisory committee examines Essure’s post-market data and peer-reviewed research. The FDA also receives reports of women claiming they suffered injuries from Essure.

October 2015

Research from The BMJ finds that women with the Essure implant are 10x more at risk of repeat procedures compared to women with tubal ligation.

2016

Significant progress has been made in state courts, and has allowed those lawsuits to proceed. Women harmed by Essure deserve to see their qualified retainers play out in court.

February 2016

Thousands of DePuy’s Attune knee systems were pulled off the market due to a surgical tool that was reportedly breaking and leaving pieces inside patients’ surgical sites. There was a wire spring coil in the Attune Knee Tibial Articulation Surface Instruments that was prone to damage. Doctors were unaware that this component was breaking and thousands of patients were at risk of complications. The Class II Device Recall dealt with more than 3,000 units.

November 2016

The FDA requires Essure to be labeled with black box warnings to indicate the dangerous health risks associated with the device.

September 2017

Bayer announces that they will end all Essure sales outside of the United States.

April 2018

Between 2002 and 2017, there were more than 26,700 complaints filed with the FDA about Essure. The large number of adverse event reports the FDA received forced the agency to restrict Essure sales in April 2018.